People who take regular doses of ibuprofen may be 40 percent less likely to develop Parkinson's disease, according to a study of more than 130,000 patients conducted by the Harvard School of Public Health.
The findings were presented yesterday at a meeting of the American Academy of Neurology in Toronto.